ID

39959

Description

ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling; ODM derived from: https://clinicaltrials.gov/show/NCT01176032

Link

https://clinicaltrials.gov/show/NCT01176032

Keywords

Versions (1)
  1. 3/6/20 3/6/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

March 6, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hypertension NCT01176032

English

Eligibility Hypertension NCT01176032

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient with hypertension
Description

Hypertensive disease

Data type

boolean

Alias
UMLS CUI [1]
C0020538
confirmed concentric left ventricular hypertrophy:
Description

Concentric hypertrophy of left ventricle

Data type

boolean

Alias
UMLS CUI [1]
C0745681
lvmi > 49.2 g/m2.7 for men and >46.7 g/m2.7 for women
Description

Left ventricular mass Index | Gender

Data type

boolean

Alias
UMLS CUI [1,1]
C0455825
UMLS CUI [1,2]
C0918012
UMLS CUI [2]
C0079399
relative wall thickness > 0.42
Description

Ventricular wall thickening Relative

Data type

boolean

Alias
UMLS CUI [1,1]
C0948228
UMLS CUI [1,2]
C0205345
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
sever or secondary htn
Description

Hypertension, severe | Secondary hypertension

Data type

boolean

Alias
UMLS CUI [1]
C4013784
UMLS CUI [2]
C0155616
lv ejection fraction of <40%
Description

Left ventricular ejection fraction

Data type

boolean

Alias
UMLS CUI [1]
C0428772
patient with compelling indication to aceis or arbs or bb
Description

Indication Angiotensin-Converting Enzyme Inhibitors | Indication Angiotensin II receptor antagonist | Indication Adrenergic beta-1 Receptor Antagonists

Data type

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0003015
UMLS CUI [2,1]
C3146298
UMLS CUI [2,2]
C0521942
UMLS CUI [3,1]
C3146298
UMLS CUI [3,2]
C0304516
history of myocardial infarction, coronary artery bypass surgery, ptc intervention, tia or stroke within 6 months of study entry
Description

Myocardial Infarction | Coronary Artery Bypass Surgery | Percutaneous transhepatic cholangiography | Transient Ischemic Attack | Cerebrovascular accident

Data type

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0010055
UMLS CUI [3]
C0203085
UMLS CUI [4]
C0007787
UMLS CUI [5]
C0038454
history of collagenopathies, osteopathy
Description

Collagen Diseases | Bone Diseases

Data type

boolean

Alias
UMLS CUI [1]
C0009326
UMLS CUI [2]
C0005940
egfr <30 ml/min/1,73 m2, serum potassium ≥5,2 meq/l
Description

Estimated Glomerular Filtration Rate | Serum potassium measurement

Data type

boolean

Alias
UMLS CUI [1]
C3811844
UMLS CUI [2]
C0302353
morbid obesity (bmi ≥ 42 kg/m2
Description

Obesity, Morbid | Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C0028756
UMLS CUI [2]
C1305855
other protocol-defined inclusion/exclusion criteria may apply
Description

Eligibility Criteria Study Protocol

Data type

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Back to the top of the page

Similar models

Eligibility Hypertension NCT01176032

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Hypertensive disease
Item
patient with hypertension
boolean
C0020538 (UMLS CUI [1])
Concentric hypertrophy of left ventricle
Item
confirmed concentric left ventricular hypertrophy:
boolean
C0745681 (UMLS CUI [1])
Left ventricular mass Index | Gender
Item
lvmi > 49.2 g/m2.7 for men and >46.7 g/m2.7 for women
boolean
C0455825 (UMLS CUI [1,1])
C0918012 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2])
Ventricular wall thickening Relative
Item
relative wall thickness > 0.42
boolean
C0948228 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Hypertension, severe | Secondary hypertension
Item
sever or secondary htn
boolean
C4013784 (UMLS CUI [1])
C0155616 (UMLS CUI [2])
Left ventricular ejection fraction
Item
lv ejection fraction of <40%
boolean
C0428772 (UMLS CUI [1])
Indication Angiotensin-Converting Enzyme Inhibitors | Indication Angiotensin II receptor antagonist | Indication Adrenergic beta-1 Receptor Antagonists
Item
patient with compelling indication to aceis or arbs or bb
boolean
C3146298 (UMLS CUI [1,1])
C0003015 (UMLS CUI [1,2])
C3146298 (UMLS CUI [2,1])
C0521942 (UMLS CUI [2,2])
C3146298 (UMLS CUI [3,1])
C0304516 (UMLS CUI [3,2])
Myocardial Infarction | Coronary Artery Bypass Surgery | Percutaneous transhepatic cholangiography | Transient Ischemic Attack | Cerebrovascular accident
Item
history of myocardial infarction, coronary artery bypass surgery, ptc intervention, tia or stroke within 6 months of study entry
boolean
C0027051 (UMLS CUI [1])
C0010055 (UMLS CUI [2])
C0203085 (UMLS CUI [3])
C0007787 (UMLS CUI [4])
C0038454 (UMLS CUI [5])
Collagen Diseases | Bone Diseases
Item
history of collagenopathies, osteopathy
boolean
C0009326 (UMLS CUI [1])
C0005940 (UMLS CUI [2])
Estimated Glomerular Filtration Rate | Serum potassium measurement
Item
egfr <30 ml/min/1,73 m2, serum potassium ≥5,2 meq/l
boolean
C3811844 (UMLS CUI [1])
C0302353 (UMLS CUI [2])
Obesity, Morbid | Body mass index
Item
morbid obesity (bmi ≥ 42 kg/m2
boolean
C0028756 (UMLS CUI [1])
C1305855 (UMLS CUI [2])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial